1P-MiPLA
 | |
 | |
| Clinical data | |
|---|---|
| Other names | 1P-MIPLA; 1-Propanoyl-lysergic acid methylisopropylamide; 1-Propanoyl-MiPLA; N,6-Dimethyl-1-propanoyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H29N3O2 |
| Molar mass | 379.504 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1P-MiPLA, also known as 1-propanoyl-lysergic acid methylisopropylamide (1-propanoyl-MiPLA), is a designer drug and presumed serotonergic psychedelic of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3] It is the 1-propanoyl derivative of MiPLA and may act as a prodrug of MiPLA.[1][2][3] 1P-MiPLA has been discussed on specialized online forums since 2018.[1] In addition, a designer drug product labeled "1P-MiPLA" but actually containing MiPLA was encountered in Austria in 2019.[1]
Use and effects
[edit]Interactions
[edit]Society and culture
[edit]Legal status
[edit]Canada
[edit]1P-MiPLA is a controlled substance in Canada under phenethylamine blanket-ban language.[4]
United States
[edit]1P-MiPLA is not an explicitly controlled substance in the United States.[5] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
See also
[edit]References
[edit]- 1 2 3 4 "1P-MiPLA". АИПСИН (AIPSIN) (in Russian). Retrieved 1 July 2025.
- 1 2 Tusiewicz K, Wachełko O, Zawadzki M, Szpot P (December 2024). "Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy". Molecules. 29 (23). Basel, Switzerland: 5717. doi:10.3390/molecules29235717. PMC 11643092. PMID 39683876.
- 1 2 Wachełko O, Nowak K, Tusiewicz K, Zawadzki M, Szpot P (2025). "A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies". The Analyst. 150 (2): 290–308. Bibcode:2025Ana...150..290W. doi:10.1039/D4AN01361A. ISSN 0003-2654. PMID 39636448. Retrieved 1 July 2025.
- ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
- ↑ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
External links
[edit] | This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information. |